BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18645603)

  • 1. Parallel gene expression profiling of mantle cell lymphoma - how do we transform 'omics data into clinical practice.
    Sara E; Borrebaeck CA
    Curr Genomics; 2007 May; 8(3):171-9. PubMed ID: 18645603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transcriptomes for serial analysis of gene expression].
    Marti J; Piquemal D; Manchon L; Commes T
    J Soc Biol; 2002; 196(4):303-7. PubMed ID: 12645300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of copy number gains and losses, detected by array-based comparative genomic hybridization, for computational differential diagnosis of B-cell lymphomas and genetic regions involved in lymphomagenesis.
    Takeuchi I; Tagawa H; Tsujikawa A; Nakagawa M; Katayama-Suguro M; Guo Y; Seto M
    Haematologica; 2009 Jan; 94(1):61-9. PubMed ID: 19029149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.
    Hansen MH; Cédile O; Blum MK; Hansen SV; Ebbesen LH; Bentzen HHN; Thomassen M; Kruse TA; Kavan S; Kjeldsen E; Kristensen TK; Haaber J; Abildgaard N; Nyvold CG
    Exp Hematol; 2020 Apr; 84():7-18.e12. PubMed ID: 32173361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-target microarray experiments: a novel experimental strategy.
    Forster T; Costa Y; Roy D; Cooke HJ; Maratou K
    BMC Genomics; 2004 Feb; 5(1):13. PubMed ID: 15018645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray.
    Oka T; Yoshino T; Hayashi K; Ohara N; Nakanishi T; Yamaai Y; Hiraki A; Sogawa CA; Kondo E; Teramoto N; Takahashi K; Tsuchiyama J; Akagi T
    Am J Pathol; 2001 Oct; 159(4):1495-505. PubMed ID: 11583976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray analysis of B-cell lymphoma cell lines with the t(14;18).
    Robetorye RS; Bohling SD; Morgan JW; Fillmore GC; Lim MS; Elenitoba-Johnson KS
    J Mol Diagn; 2002 Aug; 4(3):123-36. PubMed ID: 12169673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopathology approaches to diagnosis and prognosis of indolent B-cell lymphomas.
    Gascoyne RD
    Hematology Am Soc Hematol Educ Program; 2005; ():299-306. PubMed ID: 16304395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
    Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
    J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA microarray analysis in malignant lymphomas.
    Schwaenen C; Wessendorf S; Kestler HA; Döhner H; Lichter P; Bentz M
    Ann Hematol; 2003 Jun; 82(6):323-32. PubMed ID: 12719886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling in lymphoma diagnosis and management.
    Iqbal J; Liu Z; Deffenbacher K; Chan WC
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current approaches and developments in transcript profiling of the human placenta.
    Yong HEJ; Chan SY
    Hum Reprod Update; 2020 Nov; 26(6):799-840. PubMed ID: 33043357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.